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Human milk oligosaccharides (hMOs) are important bioactive components in mother’s
milk contributing to infant health by supporting colonization and growth of gut
microbes. In particular, Bifidobacterium genus is considered to be supported by hMOs.
Approximately 200 different hMOs have been discovered and characterized, but only
a few abundant hMOs can be produced in sufficient amounts to be applied in infant
formula. These hMOs are usually supplied in infant formula as single molecule, and it is
unknown which and how individual hMOs support growth of individual gut bacteria. To
investigate how individual hMOs influence growth of several relevant intestinal bacteria
species, we studied the effects of three hMOs (2′-fucosyllactose, 3-fucosyllactose, and
6′-sialyllactose) and an hMO acid hydrolysate (lacto-N-triose) on three Bifidobacteria
and one Faecalibacterium and introduced a co-culture system of two bacterial strains
to study possible cross-feeding in presence and absence of hMOs. We observed that in
monoculture, Bifidobacterium longum subsp. infantis could grow well on all hMOs but
in a structure-dependent way. Faecalibacterium prausnitzii reached a lower cell density
on the hMOs in stationary phase compared to glucose, while B. longum subsp. longum
and Bifidobacterium adolescentis were not able to grow on the tested hMOs. In a co-
culture of B. longum subsp. infantis with F. prausnitzii, different effects were observed
with the different hMOs; 6′-sialyllactose, rather than 2′-fucosyllactose, 3-fucosyllactose,
and lacto-N-triose, was able to promote the growth of B. longum subsp. infantis.
Our observations demonstrate that effects of hMOs on the tested gut microbiota are
hMO-specific and provide new means to support growth of these specific beneficial
microorganisms in the intestine.
Keywords: human milk oligosaccharides, co-culture, Bifidobacterium longum subsp. infantis, Faecalibacterium
prausnitzii, hMO structure-specific
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INTRODUCTION
It is widely accepted that breastfeeding is the gold standard for
infant nutrition, which offers complete nutrition for the newborn.
Mother’s milk contains bioactive components that contribute
to the healthy development of the newborn (Le Doare et al.,
2018). For these reasons, the World Health Organization (WHO)
recommends to feed infants for at least 6 months exclusively
with breastfeeding (World Health Organization [WHO], 2002;
Walker, 2010). However, for a variety of reasons, there are still
over 70% of the infants that cannot be exclusively breastfed
(Walker, 2010; Heymann et al., 2013). These non-breastfed
infants are most often fed with cow-derived infant formula
(Coulet et al., 2014; Aly et al., 2018). Up to now, these cow-
milk derived infant formula lack human milk oligosaccharides
(hMOs), which are one of the most important bioactive
components of mother’s milk. These hMOs are unique to humans
and provide numerous health-promoting effects (Bode, 2015;
Triantis et al., 2018). Until recently, it was not possible to produce
hMOs in large amounts for the application in infant formula,
but this lately changed. Major advances have been made in large-
scale production of hMOs allowing application of a few abundant
hMOs in infant formula (Vandenplas et al., 2018).
The beneficial effects of hMOs in human milk are well-
established and numerous (Bode, 2015; Cheng et al., 2019, 2020;
Kong et al., 2019). One important effect of hMOs is considered
to be the support of growth of beneficial gut bacteria (Thomson
et al., 2018). The first year of a baby’s life is critical for the
establishment of the intestinal microbiome, and hMOs are an
important factor in shaping the gut microbiome in the first
year of life (Goldsmith et al., 2015). It is, however, still unclear
which and how individual hMOs, which are already applied or
considered for infant formula, support growth of individual gut
bacteria. Bifidobacterium is one of the dominant species in the
intestine of healthy breastfed infants, and can represent up to 90%
of the total microbiome (Moore and Townsend, 2019). hMOs
are specifically known to support the growth of Bifidobacterium
genus (Thomson et al., 2018), e.g., Bifidobacterium longum subsp.
infantis, a strong hMO user that grows well when cultured with
hMOs isolated from human milk as the sole carbohydrate source
(Underwood et al., 2015). However, whether individual hMOs
currently developed for infant formula can also influence the
growth of B. longum subsp. infantis is unknown.
The infant intestine needs, however, fast colonization not
only by Bifidobacterium genus but also by other species that
contribute to making fermentation products such as short-chain
fatty acids (SCFAs) that support metabolism and immunity
(Conlon and Bird, 2015). Some bacteria ferment hMO and other
carbohydrates to produce SCFAs such as acetate, propionate, and
butyrate, which are an important energy source for intestinal
epithelium, and modulate epithelial integrity (McLeod et al.,
2019). A potent SCFA producer is, for example, Faecalibacterium
prausnitzii, which produces butyrate. This bacterium colonizes
the gut during late infancy and is one of the most dominant
bacterial species in the large intestine of healthy adults (Laursen
et al., 2017). Although its importance for a healthy gut is
broadly recognized, it is unknown how F. prausnitzii behaves
when exposed to hMOs. It is also not known how F. prausnitzii
is influenced by already present Bifidobacterium genus, and
whether it benefits from cross-feeding of hMO fermented by
Bifidobacterium genus.
To gain more insight into how currently applied or proposed
hMOs for infant formula influence growth of several relevant
intestinal species, we studied the effects of three hMOs 2′-
fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), 6′-sialyllactose
(6′-SL) and one hMO’s acid hydrolysate lacto-N-triose (LNT2)
on B. longum subsp. infantis, B. longum subsp. longum,
Bifidobacterium adolescentis, and F. prausnitzii. We first used
individual hMOs as the only carbohydrate source for different
bacterial strains in monoculture to investigate whether individual
hMOs can modulate single-strain growth. Then, B. longum
subsp. infantis and F. prausnitzii were brought into co-culture to
study the possible interaction between these two bacteria strains.
The fermentation products of B. longum subsp. infantis and
F. prausnitzii as well as glycosidic degradation of effective hMOs
under mono- and co-culture systems were analyzed.
RESULTS
Effects on Bacterial Growth of 2′-FL,
3-FL, 6′-SL, and LNT2 Were Bacterial
Strain Dependent
Figure 1 shows the growth curves of B. longum subsp. infantis,
B. longum subsp. longum, B. adolescentis, and F. prausnitzii in
YCFA broth with glucose, 2′-FL, 3-FL, 6′-SL, or LNT2 as the
single carbon source. We found that all bacterial strains were able
to grow on glucose, and the effects of 2′-FL, 3-FL, 6′-SL, and
LNT2 were variations with the tested strain. B. longum subsp.
infantis could grow on all the substrates we provided, but the
effects were hMO structure-dependent (Figure 1A). When grown
in the presence of 2′-FL, B. longum subsp. infantis could reach
OD600 of 3.6 and reach stationary phase after 56 h of culture. On
3-FL, it grew to an OD600 of 1.7 and reached stationary phase
after 32 h of culture, which was 24 h earlier than on 2′-FL. With
6′-SL, the growth of B. longum subsp. infantis started at 48 h of
culture, which is much slower than with the other substrates,
and reached an OD600 of 1.6 after 64 h of culture. On LNT2,
B. longum subsp. infantis grew to an OD600 of 1.2 and reached
stationary phase after 32 h of culture. In the presence of 2′-
FL, the OD600 of 3.6 of B. longum subsp. infantis in stationary
phase was significantly higher than with 3-FL, 6′-SL, and LNT2
as the carbon source (p < 0.0001, Supplementary Figure S1). In
contrast, B. longum subsp. longum only reached a high cell density
(OD600 > 1) on glucose, where the OD600 was 2.8 after 32 h of
culture. None of the tested hMOs was able to support the growth
of B. longum subsp. longum (Figure 1B). The growth behavior
of B. adolescentis was similar to that observed for B. longum
subsp. longum. On glucose, B. adolescentis grew to a high OD600
of 3.9 after 32 h of culture, but was not able to grow on the
different hMOs and on the hMOs acid hydrolysis product LNT2
(Figure 1C). F. prausnitzii reached a lower cell density on the
hMOs compared to glucose, and the growth pattern was hMO
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FIGURE 1 | The growth curve of (A) B. longum subsp. infantis, (B) B. longum subsp. longum, (C) B. adolescentis, and (D) F. prausnitzii in monoculture, determined
by OD600. Glucose, 2′-FL, 3-FL, 6′-SL, and LNT2 were included as a sole carbon source as indicated. Basal broth with no carbohydrates added was used as
negative control. The assays were carried out three times in duplicate. A representative curve for each condition is shown.
structure-dependent (Figure 1D). F. prausnitzii quickly reached
a final cell density at OD600 of 1.8 after 12 h of culture on glucose.
On 2′-FL and 3-FL, it reached OD600 0.2 in the stationary phase,
while with LNT2, it grew to OD600 0.3 at the endpoint. With
6′-SL, the OD600 reached 0.5 at the endpoint, which was higher
than on 2′-FL, 3-FL, and LNT2, but still significantly lower than
on glucose (p < 0.0001, Supplementary Figure S1). For the
subsequent cross-feeding studies, we selected two bacterial strains
to determine whether and which hMOs may impact the growth
of the two beneficial bacteria. We chose two essential early life
colonizing bacteria; B. longum subsp. infantis, which is a potent
hMO user, and F. prausnitzii, which is a major anti-inflammatory
commensal bacterium in early life in the gut (Sokol et al., 2008)
and a less capable utilizer of hMOs.
The Co-culture System Can Promote the
Growth of the Bacteria
We found that co-culture of B. longum subsp. infantis and
F. prausnitzii resulted in different growth rates compared to
monoculture and that it was influenced by the type of hMO. In
the presence of 2′-FL, co-culture and B. longum subsp. infantis
monoculture cell densities reached similar values (Figure 2A).
However, bacteria grew significantly faster in co-cultures than in
B. longum subsp. infantis monocultures, as co-cultures reached
stationary phase after 32 h compared to 56 h for the monoculture
of B. longum subsp. infantis (Figure 2A). In the presence of
3-FL, co-culture and B. longum subsp. infantis monoculture
reached a similar cell density, 1.80 and 1.75 at OD600, respectively,
while the F. prausnitzii monoculture reached OD600 0.2 at the
endpoint (Figure 2B). Interestingly, in the presence of 6′-SL,
the growth curves showed a similar trend as observed with
2′-FL, with the co-culture growing faster than the B. longum
subsp. infantis monoculture, albeit at an overall delayed time. The
B. longum subsp. infantis and F. prausnitzii co-culture reached
stationary phase after 48 h culturing, while the B. longum subsp.
infantis monoculture just started to grow at this time point. It
took 16 additional hours before the B. longum subsp. infantis
monoculture reached the stationary phase. At this faster growth,
the OD600 in stationary phase was 1.8 in co-culture, 1.6 in
B. longum subsp. infantis monoculture, and 0.5 in F. prausnitzii
monoculture (Figure 2C). With LNT2 as carbon source, co-
cultures and monocultures of B. longum subsp. infantis reached
stationary phases on similar time, but in co-culture, it reached a
higher cell density in stationary phase of 1.5 at OD600, while in
the monocultures of B. longum subsp. infantis and F. prausnitzii,
the cell density was only 1.15 and 0.3 at OD600, respectively,
in the stationary phase (Figure 2D). The different growth rates
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FIGURE 2 | The growth curve of B. longum subsp. infantis and F. prausnitzii in monoculture and co-cultures, determined at OD600. (A) 2′-FL, (B) 3-FL, (C) 6′-SL,
and (D) LNT2 were included as carbon source. The fermentations were carried out three times in duplicate. A representative curve for each condition is shown.
and final cell density differences in co-cultures and monocultures
containing 2′-FL, 3-FL, 6′-SL, and LNT2 as carbon source
indicate that the bacteria influence each other’s growth pattern
and promote the growth of the bacteria in an hMO structure-
dependent way.
2′-FL, 3-FL, and LNT2 Do Not Enhance
SCFA Production in Co-cultures While
6′-SL Promotes Acetate Production
As B. longum subsp. infantis ferments the hMOs (Ward et al.,
2007), we also investigated the production of SCFAs in the
mono- and co-cultures (Figures 3, 4). SCFAs are one of the
most important metabolic products of the bacteria and reflects
activity of the metabolic processes. To this end, we quantified
the SCFAs acetate, propionic acid, and butyrate after 48 h and
72 h of monoculture and co-culture. The concentrations of
the produced metabolites were calculated by subtracting the
initial values at 0 h.
Bifidobacterium longum subsp. infantis in monoculture with
glucose as carbon source (control) produced a high concentration
of acetic acid and minor amounts of propionic acid and
butyric acid at both 48 h and 72 h. Results were different
when 2′-FL, 3-FL, 6′-SL, and LNT2 were used as carbon
sources. With 2′-FL, 3-FL, and LNT2 as carbon source in
monoculture with B. longum subsp. infantis, we observed that
no significant differences were detected compared to glucose
at 48 and 72 h (Figures 3A, 4A). While on 6′-SL, no acetate
was detected after 48 h monoculture, and 7.31 µmol/mg acetate
was produced after 72 h (Figures 3A, 4A). With F. prausnitzii,
grown on glucose as carbon source, F. prausnitzii consumed
acetate in the broth and produced butyric acid and propionic
acid in monoculture (Figures 3, 4). With 2′-FL, 3-FL, 6′-SL,
and LNT2, only a small amount of butyrate was produced in
monoculture. This SCFA production was always significantly
lower than on glucose (p < 0.0001), but no significant differences
between hMOs were observed on both 48- and 72-h cultures
(Figures 3C, 4C).
When co-cultures of B. longum subsp. infantis and
F. prausnitzii were incubated with the different substrates,
high levels of acetate were observed (Figures 3A, 4A). With
regard to butyrate production, only a small amount of butyrate
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FIGURE 3 | SCFA production of glucose, 2′-FL, 3-FL, 6′-SL, and LNT2 in monoculture and co-cultures of B. longum subsp. infantis and F. prausnitzii after 48-h
cultures. The acetate (A), propionic acid (B), and butyrate (C) products of B. longum subsp. infantis and F. prausnitzii were measured after 48 h of monoculture and
co-cultures when having either 2′-FL, 3-FL, 6′-SL, and LNT2 as carbon source. Glucose served as positive control. Values are changes in concentrations calculated
by subtracting the initial values from 0 h. Data are presented as median ± range (n = 3). Statistical significance was measured using Kruskal–Wallis test followed by
the Dunn’s test and indicated by *p < 0.05, **p < 0.01, ***p < 0.001, or by ****p < 0.0001.
was detected with 2′-FL, 3-FL, 6′-SL, or LNT2 after 48 h as
well as after 72 h of culture. On glucose, we found similar
production rates of acetate when comparing B. longum subsp.
infantis monoculture and co-cultures. However, the butyrate
production of the co-culture was significantly lower when
compared to F. prausnitzii monoculture (p < 0.0001) at 48
and 72 h. For acetate production, in the presence of 2′-FL,
3-FL, or LNT2, no differences were found between B. longum
subsp. infantis monocultures and co-cultures. Interestingly,
a different result was obtained with 6′-SL. We found that in
co-cultures, 5.84 µmol/mg acetate was produced, which was
significantly higher than in monoculture of B. longum subsp.
infantis (p < 0.0001, Figure 3A), and no acetate was detected
in the monoculture of F. prausnitzii after 48-h cultures, and the
differences between co-culture and monoculture disappeared
after 72-h cultures (Figure 4A). With 2′-FL, 3-FL, 6′-SL, and
LNT2, only small amounts of butyrate were detected in co-
culture, and no significant differences were detected between the
groups at 48- and 72-h cultures.
Co-culture Promotes the Utilization of
6′-SL
As 6′-SL was differently stimulating the production of SCFAs
in co-cultures compared to monoculture of B. longum subsp.
infantis, we decided to study and compare the degradation profile
of 6′-SL in B. longum subsp. infantis monocultures and B. longum
subsp. infantis and F. prausnitzii co-cultures. To this end, we
took samples at 48 and 72 h from the B. longum subsp. infantis
monocultures and B. longum subsp. infantis and F. prausnitzii co-
cultures and studied glycosidic degradation in the samples as a
measure for carbohydrate utilization.
As shown in Figure 5, we observed that only small amounts
of 6′-SL were utilized in the monocultures of B. longum subsp.
infantis after 48 h, and the peak of 6′-SL was not decreased
in high-performance anion exchange chromatography (HPAEC)
chromatogram profiles. In contrast, a clear degradation of 6′-
SL in the B. longum subsp. infantis and F. prausnitzii co-culture
was observed after 48 h (Figure 5A). The quantification results
also showed that only 5.4% of the 6′-SL was utilized in the
monocultures of B. longum subsp. infantis after 48 h, while 65.1%
of 6′-SL in the B. longum subsp. infantis and F. prausnitzii co-
culture was consumed (Figure 5B). After 72 h, 6′-SL 74.0% and
84.7% was used in B. longum subsp. infantis monoculture and in
the co-culture system, respectively.
DISCUSSION
Human milk oligosaccharides are specifically known to support
the growth of beneficial microorganisms in the infant gut (Jost
et al., 2015). In particular, Bifidobacterium genus (Kirmiz et al.,
2018) is acknowledged for that, but which individual hMO and
how specific hMOs modulate this process is still unclear. In
the present study, our results show that the modulatory effects
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FIGURE 4 | SCFA production of glucose, 2′-FL, 3-FL, 6′-SL, and LNT2 in monoculture and co-cultures of B. longum subsp. infantis and F. prausnitzii after 72-h
cultures. The acetate (A), propionic acid (B), and butyrate (C) products of B. longum subsp. infantis and F. prausnitzii were measured after 72 h of monoculture and
co-cultures when having either 2′-FL, 3-FL, 6′-SL, and LNT2 as carbon source. Glucose served as positive control. Values are changes in concentrations calculated
by subtracting the initial values from 0 h. Data are presented as median ± range (n = 3). Statistical significance was measured using Kruskal–Wallis test followed by
the Dunn’s test and indicated by *p < 0.05, **p < 0.01, ***p < 0.001, or by ****p < 0.0001.
of individual hMOs on bacterial growth are strongly structure-
dependent in both monoculture and co-cultures.
In monoculture, the effects of 2′-FL, 3-FL, 6′-SL, and LNT2
on bacterial growth are bacterial strain- as well as hMO
structure-dependent. Different growth patterns were observed
for different bacteria strains when exposed to the same hMO.
The growth of bacteria on 2′-FL, 3-FL, 6′-SL, and LNT2 was
hMO structure-dependent. As shown in Figure 6, hMOs are
composed of five monomers: D-glucose (Glc), D-galactose (Gal),
N-acetylglucosamine (GlcNAc), L-fucose (Fuc), and sialic acid
(Sia) (Figure 6A). All hMOs are synthesized from lactose (Galβ1-
4Glc), which can be further extended and form more than 200
different structures of hMOs (Figure 6B; Bode, 2015; Thurl et al.,
2017). Several studies have demonstrated that the individual
hMOs have different effects and that the final outcome of a
specific health benefit depends on the composition of individual
hMOs (Cheng et al., 2019, 2020; Kong et al., 2019). In the
current study, we found that B. longum subsp. infantis grew
faster on 3-FL as carbon source and reached higher cell densities
on 2′-FL. 2′-FL and 3-FL are both trisaccharide hMOs that are
formed by fucosylation of lactose. The molecules have the same
molecular composition and only differ in the attachment position
of L-fucose (Fuc) residues on the lactose core region (Figure 6C).
The fermentation of both 2′-FL and 3-FL by bacteria occurs via
bacterial α-fucosidase and β-galactosidase enzymes (Thomson
et al., 2018), and we observed that the growth rate was higher
with 3-FL, and the final cell density was higher with 2′-FL.
This indicates different kinetics of fermentation of 2′-FL and 3-
FL by B. longum subsp. infantis. Different enzymes are needed
to ferment 6′-SL and LNT2. For fermenting 6′-SL, the bacteria
need β-galactosidase and α-sialidase, and fermentation of LNT2
requires β-galactosidase and β-hexosaminidase (Thomson et al.,
2018). The different growth patterns of B. longum subsp. infantis
on individual hMOs might be impacted by the catalytic ability of
the enzymes. The observation that F. prausnitzii reaches a higher
final OD600 on 6′-SL than when grown with 2′-FL, 3-FL, or LNT2
suggests that F. prausnitzii has a higher α-sialidase activity and
less α-fucosidase and β-hexosaminidase activity.
Bifidobacterium longum subsp. infantis produce a high
concentration of acetic acid, with minor amounts of propionic
acid and butyric acid, while F. prausnitzii used acetate in
the broth and produced butyric acid (Moens et al., 2016).
In the co-culture system, the growth rate was higher than in
monoculture of the individual strains. Therefore, we decided to
investigate whether the acetate supplied by B. longum subsp.
infantis would stimulate the metabolic activity of F. prausnitzii
in co-culture. Hence, the SCFA production was quantified and
compared between monoculture and co-cultures of B. longum
subsp. infantis and F. prausnitzii. Interestingly, under all co-
culture conditions tested, no butyrate was detected after 48 h of
culture, which suggests that F. prausnitzii, while being a potent
butyrate producer, was not able to grow in co-culture. This might
be associated with the hMO utilization strategy of B. longum
subsp. infantis (Thomson et al., 2018). The utilization of hMOs
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FIGURE 5 | Degradation of 6′-SL after 48-h and 72-h fermentation by
B. longum subsp. infantis and F. prausnitzii in mono- and co-cultures.
(A) HPAEC chromatogram profiles of 6′-SL when B. longum subsp. infantis in
monoculture or co-culture with F. prausnitzii after 48 h and 72 h. (B) The
percentage of remaining 6′-SL in the broth when B. longum subsp. infantis
was in monoculture or co-culture with F. prausnitzii after 48 h and 72 h.
by B. longum subsp. infantis is based on the uptake of intact
hMOs inside the bacteria, where it is intracellularly degraded
(Garrido et al., 2011).
Although F. prausnitzii was not able to grow in the co-
cultures, we still observed that with 6′-SL as carbon source,
B. longum subsp. infantis and F. prausnitzii co-cultures had
higher growth rates than in the monocultures (Figure 2C).
This indicated that the presence of F. prausnitzii may promote
the growth of B. longum subsp. infantis on 6′-SL in co-
culture. Since only a small amount of butyrate was produced in
F. prausnitzii monoculture as well as co-culture (Figures 3, 4),
and since there were no statistically significant difference between
F. prausnitzii monoculture and co-culture, we concluded that 6′-
SL was not substantially fermented by F. prausnitzii. Therefore
the degradation of 6′-SL in F. prausnitzii monoculture was not
included. This is in accordance with the SCFA production and
carbohydrate degradation results, which showed that B. longum
subsp. infantis and F. prausnitzii co-culture promotes acetate
production and 6′-SL utilization. However, this promoting effect
of F. prausnitzii was only observed on 6′-SL, and not on 2′-
FL, 3-FL, and LNT2. As only the utilization of 6′-SL involves a
sialidase (Thomson et al., 2018), we hypothesized that the co-
culture of B. longum subsp. infantis and F. prausnitzii might
enhance sialidase expression, as only 6′-SL promoted the growth
and metabolism of B. longum subsp. infantis. However, in the
current study, only one sialylated hMO was included. Hence, in
order to confirm this hypothesis, more sialylated hMOs, such
as 3′-sialyllactose (3′-SL), are needed. Unfortunately, due to the
technical limitations, pure 3′-SL is not available yet, but would be
of great value to test our hypothesis.
In conclusion, we demonstrate that the utilization of
individual hMOs as sole carbohydrate sources is bacterial strain-
and hMO structure-dependent. Our results show that hMOs
currently applied or developed to be applied in infant formula
are able to modulate the growth of B. longum subsp. infantis
in a structure-dependent way and stimulate further growth of
B. longum subsp. infantis during co-cultures. In particular, 6′-SL,
which can promote the growth of B. longum subsp. infantis in
B. longum subsp. infantis and F. prausnitzii co-culture, showed
promising results. Again, we demonstrate that the effects of
individual hMOs are highly structure-dependent (Cheng et al.,
2019; Kong et al., 2019). Small differences in the molecular
structure of hMOs can have significant impact on their biological
efficacy. Follow-up studies are needed to identify the specific
structure responsible for modulation of bacterial growth, e.g.,
impact of other sialylated hMOs, which might provide new
effective and targeted ways of supporting the growth of beneficial
microorganisms in the infant intestine.
MATERIALS AND METHODS
Components
In the present study, 2′-FL (provided by FrieslandCampina
Domo, Amersfoort, Netherlands), 3-FL, 6′-SL, and LNT2
(provided by Glycosyn LLC, Woburn, MA, United States) were
tested. An overview of the structures of these components are
shown in Table 1.
Bacterial Strains
Faecalibacterium prausnitzii A2-165 (DSM 17677) was obtained
from the Deutsche Sammlung von Mikroorganismen and
Zellkulturen (DSMZ, Göttingen, Germany). B. longum
subsp. longum, B. longum subsp. infantis ATCC 15697, and
B. adolescentis (collection strain, NIZO B659) were kindly
provided by HH, Department of Medical Microbiology,
University Medical Center Groningen (UMCG, Groningen,
Netherlands).
Growth Broth, Monoculture, and
Co-culture Conditions
All strains were grown and maintained in yeast extract, casitone,
and fatty acid broth (YCFA) (Lopez-Siles et al., 2012). First, the
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FIGURE 6 | Structures of hMOs. (A) Building blocks of hMOs. (B) Structural blueprint of hMOs. (C) Lactose is fucosylated through different linkages to generate
2′-FL and 3-FL.
growth and substrate fermentation capacities of the individual
strains on different hMO sources were studied. In order to do
this, various hMOs were added to the broth at a concentration of
5 mg/ml. YCFA containing 5 mg/ml glucose (Thermo Scientific,
Breda, Netherlands) was used as a positive control, while media
without carbohydrate served as a negative control. Broth was
autoclaved at 121◦C for 20 min first, after which the carbohydrate
source was added to the cooled broth after sterile filtration.
The final pH of the broth was adjusted to 6.5 ± 0.1 by
using sterile HCl.
All strains were inoculated in 5 ml of YCFA broth
supplemented with glucose as the sole energy source (YCFAG)
TABLE 1 | Overview of the structures of selected hMOs.






and incubated anaerobically at 37◦C for 24 h. Subsequently,
the strains were propagated to 5 ml of YCFAG broth culture
overnight as pre-culture; after that, different strains were added to
the tubes of YCFA broth supplemented with the different carbon
sources at a ratio of 1:100 in duplicate at 37◦C. Growth in cultures
was monitored spectrophotometrically every 4 h from 0- to 72-h
culture by measuring the OD600 by using Ultrospec 10 cell density
meter (Amersham Biosciences GmbH, Germany).
To study the interaction between B. longum subsp. infantis and
F. prausnitzii, co-culture fermentations were performed in YCFA
with 5 mg/ml of the different carbon sources. B. longum subsp.
infantis and F. prausnitzii cells were inoculated as described
above. Subsequently, the strains were propagated to 5 ml of
YCFAG media and were pre-cultured separately, and the cell
density was monitored spectrophotometrically by measuring the
OD600 using Ultrospec 10 cell density meter. When OD600
reached 1.0 in the pre-culture, B. longum subsp. infantis and
F. prausnitzii were added to the same tube of YCFA broth
supplemented with the different carbon sources at a ratio of 1:100.
Each batch of experiments was made with the same inocula for
both B. longum subsp. infantis and F. prausnitzii.
SCFA Production
Samples for the SCFA analyses were taken at 48 h and 72 h of
monoculture and co-culture incubation. The fermentation digest
(0.5 ml) was heated at 100◦C for 5 min and then centrifuged at
13,200 × g for 10 min at room temperature. Analysis of SCFAs
(acetate, propionate, and butyrate) by gas chromatography (GC)
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was done as described previously by Gu et al. (2018). A 250-µl
aliquot of the fivefold diluted supernatant of the fermentation
product was mixed with 125 µl of a solution containing oxalic
acid (0.09 M), HCl (0.3 M), and internal standard 2-ethyl butyric
acid (0.45 mg/ml). Afterward, the mixture was allowed to stand
at room temperature for 30 min. The temperature profile during
GC analysis was as follows: 100◦C, maintained for 0.5 min; raised
to 180◦C at 8◦C/min, maintained for 1 min; raised to 200◦C
at 20◦C/min, maintained for 5 min. Xcalibur software (Thermo
Scientific, Breda, Netherlands) was used to process data from GC.
Glycosidic Degradation
Samples for the degradation analysis were taken at 48 and
72 h of B. longum subsp. infantis monoculture and co-culture.
HPAEC was used to measure the carbohydrate degradation as a
measure for utilization of carbohydrates by the microorganisms
(Cardarelli et al., 2016). An ISC 3000 (Dionex, Sunnyvale, CA,
United States), equipped with a 2 × 250 mm Dionex CarboPac
PA-1 column and a 2× 50 mm CarboPac PA-1 guard column, was
used for quantification (Albrecht et al., 2009). Briefly, samples
were adjusted to a final concentration of 0.05 mg of the substrate
per milliliter, and 10 µl of the samples was injected using a
Dionex ISC3000 autosampler. The oligosaccharides were eluted
(0.3 ml/min) by a gradient of 0–350 mM sodium acetate in
100 mM NaOH for 35 min. Each elution was followed by a
washing step with 1 M NaOAc in 100 mM NaOH for 5 min and
an equilibration step with 100 mM NaOH for 15 min. A Dionex
ED40 detector in pulsed amperometric detection mode was
used for detection. 6′-SL at final concentrations of 0.05 mg/ml
were used as standards. Chromeleon software Version 6.70
(Dionex) was used for the integration and evaluation of the
chromatograms obtained.
Statistics
The results were analyzed using GraphPad Prism. The normality
of distribution of the data was tested by using the Kolmogorov–
Smirnov test. Values are expressed as median ± range. Statistical
comparisons were performed using the Kruskal–Wallis test
followed by the Dunn’s test. p < 0.05 was considered as
statistically significant (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
∗∗∗∗p < 0.0001).
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